NetworkNewsBreaks

ThursdayMay 23, 2024 12:34 pm

NetworkNewsBreaks – CWCBExpo Continues Collaboration with CannabisNewsWire, IBN to Enhance Visibility of Upcoming Expo

CWCBExpo (Cannabis World Congress & Business Exposition), a market-leading and sector-shaping event series in the cannabis, CBD and hemp space, has selected CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands of IBN (“InvestorBrandNetwork”), as the Official NewsWire sponsor to enhance visibility and recognition of its upcoming expo. In addition, CWCBExpo has selected IBN as the Official Media Sponsor of the event, scheduled to be held at New York City’s Javits Convention Center on June 5-6, 2024. According to the announcement, IBN and CNW will work in conjunction to leverage IBN’s extensive array…

Continue Reading

ThursdayMay 23, 2024 12:09 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized, crossover investigation that will compare injected Zepbound tirzepatide by Eli Lilly to a compound formulated, DehydraTECH-processed tirzepatide that is derived from Zepbound but in a capsule form. Test articles for the study will be manufactured…

Continue Reading

WednesdayMay 22, 2024 3:45 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Looking to Transform Healthcare for Individuals with Neurodegenerative Diseases

Clene (NASDAQ: CLNN) has innovated CNM-Au8(R), an oral nanotherapeutic designed to revitalize the brain’s mitochondrial function, which is a significant advancement for the treatment of neurodegenerative disease. “The inspiration for CNM-Au8 comes from the therapeutic potential of elemental metals, a concept understood in both Western and Eastern medicine traditions. Clene’s approach, which leverages nanotechnology, focuses on improving mitochondrial function to support the complex electrical activity necessary for movement, cognitive function and more. Clene’s CEO, Rob Etherington, highlighted that CNM-Au8 is tailored to address the central nervous system needs, targeting diseases like ALS and MS… Clinical trials of CNM-Au8 have shown…

Continue Reading

WednesdayMay 22, 2024 2:59 pm

NetworkNewsBreaks – AROYA Marks Release of 100th Episode of ‘Office Hours Live,’ Designed to Provide Cannabis Cultivation Guidance, Support and Community

AROYA, the leading cannabis cultivation platform, has reached a significant milestone for “Office Hours Live,” its popular podcast series. According to the announcement, “Office Hours Live” recently released its 100th episode, with each episode focused on providing free, science-based and expert-approved guidance on cannabis cultivation. Hosted by cannabis cultivation experts Seth Baumgartner and Jason Van Leuven, the series has had millions of views and downloads worldwide, answered more than 900 cultivator questions and featured 13 guests from various sectors of the cannabis industry; the episodes also include live question-and-answer segments where participants can interact directly with the hosts. “We created…

Continue Reading

WednesdayMay 22, 2024 2:52 pm

NetworkNewsBreaks – CWCBExpo Names Josh Kesselman as Keynote Speaker for 10th Annual Trade Show and Conference

Cannabis World Congress & Business Exposition (“CWCBExpo”), the premier East Coast trade show and conference dedicated to the legalized cannabis industry, has announced the keynote speaker for next month’s event. According to the announcement, Josh Kesselman, iconic CEO and philanthropic founder of HBI International, will provide the main address. HBI International is the company behind RAW Rolling Papers. The CWCB Expo is scheduled for June 5–6, 2024, in New York City. Kesselman will open the event, presenting on the main stage at 11 a.m. ET on June 5; his presentation, which will be styled after a fireside chat, will be hosted by…

Continue Reading

WednesdayMay 22, 2024 2:47 pm

NetworkNewsBreaks – Sustain SoCal to Showcase Evolving Trends in Mobility at Upcoming Event

Sustain Southern California (“Sustain SoCal”) today announced that it will host the 11th Annual Driving Mobility Symposium (“Driving Mobility 11”) on Thursday, June 27, 2024. The event is slated to take place at UCI Beall Applied Innovation in Irvine, California. Driving Mobility 11 is focused on evolving trends in mobility and advanced transportation in Southern California and beyond. The EXPO provides industry professionals and students a unique opportunity to interact with cutting-edge technologies in the mobility decarbonization space and associated industries. “Now in its 11th edition, the Driving Mobility series has played a pivotal role in empowering the mobility ecosystem…

Continue Reading

WednesdayMay 22, 2024 2:46 pm

NetworkNewsBreaks – SOHM, Inc. (SHMN) Continues to Advance Groundbreaking Technology

SOHM (OTC: SHMN), a leading generic pharmaceutical and upstart biotechnology company, today announced its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. The technology holds the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells. The revolutionary new ABBIE system, due to SOHM’s committed, consistent and focused approach by lead scientists at its lab at UACI in Tucson, Arizona, is due to be sold as off-the-shelf kits in the third quarter of this year. “We are…

Continue Reading

WednesdayMay 22, 2024 2:20 pm

NetworkNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FSE: 9NH) Set to Commence New Exploration Program at Duquesne West Gold Project

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FSE: 9NH) announced that it has mobilized a drill rig for its 2024 exploration program at the Duquesne West Gold Project in Quebec, with the 8,000 m drill program set to commence by mid-May to follow up on the results of Emperor’s initial 2023 drill campaign. Globex Mining Enterprises Inc. (TSX: GMX) (OTCQX: GLBXF) (FSE: G1MN) further elaborated on the news, stating, “Emperor has taken a binary approach to exploration on the property seeking to outline an open-pittable, lower grade, large tonnage gold deposit in addition to the more conventional high-grade underground mine as…

Continue Reading

WednesdayMay 22, 2024 2:09 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) CEO Urges Leaders to Plan for AI and Quantum Future

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, today announced that Dr. Alan Baratz, CEO of D-Wave, has published a new guest column as part of the Forbes Technology Council that calls upon business leaders to immediately prioritize the exploration of quantum computing as they continue to accelerate their artificial intelligence (AI) adoption. In his column, Dr. Baratz explains that as AI continues to advance, it also consumes significant amounts of energy, and quantum computing could be used to identify and develop more powerful and sustainable AI models. “With sustainability now an added…

Continue Reading

WednesdayMay 22, 2024 1:53 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments

PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, recently took swift action to address a pressing medical situation unfolding in Malawi, East Africa. “The Ministry of Health (‘MOH’) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping sickness crisis affecting the region. PaxMedica responded to this call for help by committing to provide emergency access to its recently completed registration batches of PAX-101, an IV form of suramin. This decision underscores PaxMedica’s dedication to mitigating the devastating impact of sleeping sickness and ensuring access to…

Continue Reading